John Sharkey - Jun 5, 2025 Form 4 Insider Report for GeoVax Labs, Inc. (GOVX)

Role: VP, Business Development
Signature: /s/ John Sharkey
Stock symbol: GOVX
Transactions as of: Jun 5, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/6/2025, 09:39 AM
Previous filing: Apr 10, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sharkey John W.	VP, Business Development	1900 LAKE PARK DRIVE, SUITE 380, SMYRNA	/s/ John Sharkey	2025-06-06	0001515991

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GOVX	Stock Option	Award	$0	+70K		$0.00	70K	Jun 5, 2025	Common Stock	70K	$2.48	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.
F2	This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan. Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.

Content

Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan. Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.